A detailed history of Omers Administration Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Omers Administration Corp holds 21,647 shares of RDY stock, worth $302,408. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,647
Previous 26,247 17.53%
Holding current value
$302,408
Previous $2 Million 14.01%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$75.41 - $84.21 $346,886 - $387,366
-4,600 Reduced 17.53%
21,647 $1.72 Million
Q2 2024

Aug 13, 2024

BUY
$68.26 - $76.19 $515,158 - $575,005
7,547 Added 40.36%
26,247 $2 Million
Q1 2024

May 14, 2024

SELL
$67.36 - $77.59 $788,112 - $907,803
-11,700 Reduced 38.49%
18,700 $1.37 Million
Q4 2023

Feb 13, 2024

BUY
$64.27 - $69.9 $1.95 Million - $2.12 Million
30,400 New
30,400 $2.12 Million
Q1 2020

May 15, 2020

SELL
$34.75 - $45.85 $6.97 Million - $9.2 Million
-200,700 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$36.66 - $41.78 $54,989 - $62,670
-1,500 Reduced 0.74%
200,700 $8.14 Million
Q3 2019

Nov 12, 2019

BUY
$34.82 - $39.26 $1.28 Million - $1.44 Million
36,700 Added 22.18%
202,200 $7.66 Million
Q2 2019

Aug 08, 2019

BUY
$36.05 - $42.76 $1.12 Million - $1.33 Million
31,200 Added 23.23%
165,500 $6.29 Million
Q1 2019

May 15, 2019

SELL
$35.77 - $40.57 $668,899 - $758,659
-18,700 Reduced 12.22%
134,300 $5.64 Million
Q4 2018

Feb 14, 2019

BUY
$31.89 - $38.44 $408,192 - $492,032
12,800 Added 9.13%
153,000 $5.77 Million
Q3 2018

Nov 14, 2018

BUY
$29.25 - $36.73 $4.1 Million - $5.15 Million
140,200 New
140,200 $4.85 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.32B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.